N-Acetylmorpholine

We are N-Acetylmorpholine CAS:1696-20-4 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 1696-20-4
Product Name: N-Acetylmorpholine
Other Name:
N-Acetylmorpholine
4-Acetylmorpholine
1-(Morpholin-4-yl)ethanone
1-(4-Morpholinyl)ethanone
1-Morpholinoethanone
1-morpholin-4-ylethanone
 
Density: 1.116
Boiling Point: 245.5 ºC
Melting Point: 9-10 ºC
Molecular Formula: C6H11NO2
Molecular Weight: 129.157
Flash Point: 122 ºC
Exact Mass: 129.078979
PSA: 29.54000
LogP: -0.32
Vapour Pressure: 0.0±0.5 mmHg at 25°C
Index of Refraction: 1.483-1.485
Water Solubility: MISCIBLE
 
Specification
Appearance:  Colorless or Light yellow liquid
Assay: ≥99.0%
Loss on drying: ≤0.5%
Methyl morpholine: ≤0.2%
 
Application
Intermediates of Flumorph CAS: 211867-47-9.
Intermediates of Dimethomorph CAS: 110488-70-5.
Be used as pesticide intermediate, mainly used in the synthesis of fungicide.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

N-Acetylmorpholine


Related News: Taking Teva as an example, it has 2 large R & D centers and 3 professional R & D centers in 5 countries, which effectively supports the development of Teva’s generic pharmaceutical sector.145238-17-1 Taking Teva as an example, it has 2 large R & D centers and 3 professional R & D centers in 5 countries, which effectively supports the development of Teva’s generic pharmaceutical sector.Fosfito de trimetilo CAS:121-45-9 This time frame optimizes the opportunity to respond to treatment with an HMA prior to declaring treatment failure, as per NCCN Guidelines. Patients are randomized at a 2:1 ratio into two study arms: IV rigosertib plus Best Supportive Care versus Physician’s Choice plus Best Supportive Care.2- (2-aminopropan-2-il) -N – [(4-fluorofenil) metil] -5-hidroxi-1-metil-6-oxopirimidina-4-carboxamida CAS:518048-03-8 The acquired pharmaceutical intermediates business will be renamed Corden Pharma Switzerland LLC and will operate as part of ICIG’s pharmaceutical business within the Corden Pharma platform. The companies’ goal is to close the transaction during the first quarter of 2011. Financial terms are not disclosed.The use of contrast agents is different from other drugs, and it needs to be used with corresponding equipment. In recent years, China is in the growth period of imaging equipment.

Related Products
Product Name
9-Bromo-10-phenylanthracene View Details
5-Bromo-2-nitrobenzotrifluoride View Details
5-Fluoro-2-methylindole View Details
(S)-3-Fluoropyrrolidine hydrochloride manufacturer 2-Fluoro-6-Methoxybenzonitrile manufacturer 2-Amino-5-nitro-4-picoline manufacturer 1-Methyl-4-(4-piperidinyl)piperazine dihydrochloride manufacturer 2-((4-Methyl-2-nitrophenyl)amino)ethanol manufacturer